IP Library Granted Patent US 8,609,409
Granted Patent B2
US 8,609,409 · App. 13/598,343 · Granted Dec 17, 2013

Methods and compositions for cell culture platform

Inventors: Xiaowei Li (Charleston, SC); Ning Zhang (Mount Pleasant, SC); Xuejun Wen (Charleston, SC)
Assignee: Clemson University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,609,409
App. No.
13/598,343
Granted
Dec 17, 2013
Kind
B2
Abstract

The present invention provides a synthetic cell culture platform, comprising: a two dimensional and/or three dimensional surface comprising peptides conjugated to said surface and methods of using the platform for increasing cell adhesion, stable attachment and/or proliferation of cells grown on the platform and for promoting differentiation of neural stem cells into neurons.

Claims (12)

1. A cell culture platform, comprising: a two dimensional and/or three dimensional surface comprising peptides conjugated to said surface, wherein said peptides comprise the amino acid sequence CCRRIKVAVWLC (SEQ ID NO: 1).

2. The cell culture platform of claim 1 , wherein the two dimensional surface is an in vitro cell culturing surface.

3. The cell culture platform of claim 1 , wherein the three dimensional surface is a hydrogel.

4. The cell culture platform of claim 1 , wherein the peptides are conjugated to said surface at a concentration of 10 μM or less.

5. A method of increasing cell adhesion, stable attachment and/or proliferation of cells on two dimensional and/or three dimensional surfaces, comprising:

contacting the cells with the platform of claim 1 ; and

culturing the cells, wherein the cultured cells have increased cell adhesion, stable attachment and proliferation as compared to a control.

6. The method of claim 5 , wherein the cells are stem cells.

7. The method of claim 6 , wherein the stem cells are neural stem cells or neural progenitor cells (NPCs).

8. The method of claim 7 , wherein the neural stem cells or neural progenitor cells are human.

9. A method of promoting differentiation of neural stem cells or neural progenitor cells into neurons, comprising: contacting neural stem cells or neural progenitor cells with the platform of claim 1 ; and culturing the cells on said platform, thereby promoting the differentiation of the cells into neurons.

10. The method of claim 9 , wherein the neural stem cells or neural progenitor cells are human.

Assignments (4)
CONFIRMATORY LICENSE Recorded Dec 10, 2015
From: CLEMSON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037260/0081 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2014
From: CLEMSON UNIVERSITY
To: CLEMSON UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 032065/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2012
From: LI, XIAOWEI; ZHANG, NING; WEN, XUEJUN
To: CLEMSON UNIVERSITY
Reel/Frame 029320/0533 →
CONFIRMATORY LICENSE Recorded Oct 23, 2012
From: CLEMSON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029176/0229 →
Continuity (4)
Continuation In Part 13447041 · Apr 13, 2012
Continuation In Part 12794556 · Jun 4, 2010
Provisional Application 61184163 · Jun 4, 2009
Related Publication 20130288366A1 · Oct 31, 2013